Exception Cementless Hip Stem (Exception)
Exception Cementless Femoral Stem in Total Hip Arthroplasty. A Multicenter, Retrospective and Prospective, Non-controlled Post Market Clinical Follow-up Study (Implants and Instrumentation)
Sponsor: Zimmer Biomet
This observational or N/A phase trial investigates Avascular Necrosis of Hip and Congenital Hip Dysplasia and is currently ongoing. Zimmer Biomet leads this study, which shows 10 recorded versions since 2021 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
10 versions recorded-
Jul 2025 — Present [monthly]
Active Not Recruiting
-
Sep 2024 — Jul 2025 [monthly]
Active Not Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Active Not Recruiting
Status: Recruiting → Active Not Recruiting
-
Oct 2023 — Jul 2024 [monthly]
Recruiting
-
Sep 2022 — Oct 2023 [monthly]
Recruiting
▶ Show 5 earlier versions
-
May 2021 — Sep 2022 [monthly]
Recruiting
Status: Not Yet Recruiting → Recruiting
-
Jan 2021 — May 2021 [monthly]
Not Yet Recruiting
-
Oct 2020 — Jan 2021 [monthly]
Not Yet Recruiting
-
Jul 2020 — Oct 2020 [monthly]
Not Yet Recruiting
-
May 2020 — Jul 2020 [monthly]
Not Yet Recruiting
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Zimmer Biomet
For direct contact, visit the study record on ClinicalTrials.gov .